Paul Billings – EIR’s


Board certified internist and clinical geneticist, Dr. Paul R. Billings serves as Chief Medical Officer of Life Technologies Corporation (NASDAQ: LIFE), a unique position aimed at improving patient care through expanding the use of medically relevant genomic technologies in clinical settings. Dr. Billings has extensive expertise and health care experience in the areas of genomics and molecular medicine. He currently serves on the Scientific Advisory Board of the Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the National Academy of Sciences Institute of Medicine’s Roundtable on Genomics. Most recently, Dr. Billings was the Director and Chief Scientific Officer of the Genomic Medicine Institute at El Camino Hospital, the largest community hospital in the Silicon Valley. He was also a member of the United States Department of Health and Human Services Secretary’s Advisory Committee on Genetics, Health and Society before it was disbanded. Dr. Billings has had a distinguished career as a physician and researcher. He has been a founder or chief executive officer of companies involved in genetic and diagnostic medicine including
GeneSage Inc., Omicia Inc. and CELLective Dx Corporation and was senior vice president for corporate development at Laboratory Corporation of America Holdings (NYSE; LH). He has held academic appointments at some of the most prestigious universities in the United States including Harvard University, U.C. San Francisco, Stanford University and U. C. Berkeley, and has served as a physician at a number of prestigious medical centers. He is the author of nearly 200 publications and books on experimental and clinical medicine. His work on genetic discrimination was instrumental in the creation and passage of the federal Genetic Information Non-Discrimination Act of 2008. Dr. Billings holds an M.D. from Harvard Medical School and a Ph.D. in immunology from Harvard University. Prior to their recent transactions, Dr. Billings was a Director of (NASDAQ: ACOM), the Executive Chairman of Signature Genomics Inc., and a Founder of the Cordblood Registry, Inc. He is a long time Board Member of the
Council for Responsible Genetics, the country’s oldest independent biotechnology “watchdog” organization.